# The Safety and Influencing Factors of Liwen Procedure in The Treatment of Hypertrophic Cardiomyopathy

> **NCT06003478** · — · UNKNOWN · sponsor: **Xijing Hospital** · enrollment: 486 (estimated)

## Conditions studied

- Hypertrophic Obstructive Cardiomyopathy

## Interventions

- **PROCEDURE:** Percutaneous Intramyocardial Septal Radiofrequency Ablation for hypertrophic obstructive cardiomyopathy (Liwen Procedure)

## Key facts

- **NCT ID:** NCT06003478
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-21
- **Primary completion:** 2024-05-30
- **Final completion:** 2024-05-30
- **Target enrollment:** 486 (ESTIMATED)
- **Last updated:** 2023-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06003478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06003478, "The Safety and Influencing Factors of Liwen Procedure in The Treatment of Hypertrophic Cardiomyopathy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06003478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*